pharmaceutical investing Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm Sublingual Film
pharmaceutical investing Aquestive Therapeutics to Participate in Upcoming September Investor Conferences
pharmaceutical investing Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
pharmaceutical investing Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm Sublingual Film
pharmaceutical investing Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET
pharmaceutical investing Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
pharmaceutical investing Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
pharmaceutical investing Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET
Syntholene Engages Imperial College of London Expert for Independent Technical Review of Operating Data from Iceland Demonstration Facility
QIMC Ties New Salem-Apple River Helium Zones to a Buried Basement Structure: Gravity, Magnetics and Geochemistry Converge on a Single Fault-Bounded Ramp
